Ursprung des Netzwerks ersten Grades von Brennan Doyle
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Brennan Doyle
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Sales & Marketing | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| INDIVIOR PLC | Pharmaceuticals: Major | General Counsel | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree | |
| University of Rhode Island | College/University | Undergraduate Degree | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Masters Business Admin | |
| Syracuse University | College/University | Undergraduate Degree | |
| Manhattan College | College/University | Undergraduate Degree | |
| St. John's University | College/University | Doctorate Degree | |
| University of Michigan | College/University | Graduate Degree | |
| Virginia Commonwealth University | College/University | Doctorate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Director/Board Member | ||
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | General Counsel | |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals US, Inc. is based in Titusville, NJ. Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes, and markets drugs. The CEO of the company is Samuele Butera. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The Sophie Davis School of Biomedical Education | College/University | Undergraduate Degree | |
| Berlex Laboratories, Inc. | General Counsel General Counsel | ||
| QUINCE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Data Processing Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Reckitt Benckiser LLC
 Reckitt Benckiser LLC Pharmaceuticals: MajorHealth Technology Part of Reckitt Benckiser Group Plc, Reckitt Benckiser LLC is a manufacturer of household, health and personal care, and food products. | Pharmaceuticals: Major | General Counsel | |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Packaged Software | Director/Board Member | |
| L. M. College of Pharmacy | College/University | Undergraduate Degree | |
| VYNE THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ORGANON & CO. | Pharmaceuticals: Major | General Counsel | |
BJ's Produce, Inc
 BJ's Produce, Inc Agricultural Commodities/MillingProcess Industries Part of Glass House LLP, BJ's Produce, Inc is a company that engages in farming hydroponic lettuce and herbs. The company is based in Miami, FL. BJ's Produce was acquired by Glass House LLP on 2021-10-12. | Agricultural Commodities/Milling | President | |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Biotechnology | Director/Board Member Director/Board Member | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OnkosXcel Therapeutics LLC
 OnkosXcel Therapeutics LLC Medical/Nursing ServicesHealth Services Part of BioXcel Therapeutics, Inc., OnkosXcel Therapeutics LLC operates as an oncology clinic. The company is based in New Haven, CT. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer |
Statistik
International
| Vereinigte Staaten | 44 |
| Vereinigtes Königreich | 3 |
| Deutschland | 2 |
| Israel | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Health Services | 3 |
| Technology Services | 3 |
Operativ
| Corporate Officer/Principal | 37 |
| Director/Board Member | 35 |
| Chief Tech/Sci/R&D Officer | 15 |
| Independent Dir/Board Member | 14 |
| Undergraduate Degree | 12 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Mueller | 15 |
| Michael Miller | 14 |
| Sandeep Laumas | 14 |
| Richard Steinhart | 12 |
| Rajiv Patni | 12 |
| Javier Rodriguez | 11 |
| Vincent O'Neill | 9 |
| June Bray | 9 |
| Vimal Mehta | 8 |
| Michal Votruba | 7 |
| Frank Yocca | 7 |
| Matthew Wiley | 7 |
| Chetan Lathia | 5 |
| Erik Kopp | 2 |
- Börse
- Insiders
- Brennan Doyle
- Unternehmensverbindungen
